Mitochondrial function as a therapeutic target in heart failure
Virginia Tech · Henry Ford Hospital · +16 more institutions
Abstract
The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the mechanisms of mitochondrial dysfunction in heart failure are presented, along with an overview of emerging treatments with the potential to improve the function of the failing heart by targeting mitochondria. Heart failure is a pressing worldwide public-health problem with millions of patients having worsening heart failure. Despite all the available therapies, the condition carries a very poor prognosis. Existing therapies provide symptomatic and clinical benefit, but do not fully address molecular abnormalities that occur…
Citation impact
- FWCI
- 26.46
- Percentile
- 100%
- References
- 256
Authors
16Topics & keywords
- Heart failure
- Medicine
- Mitochondrion
- Bioinformatics
- Cardiac function curve
- Cardiology
- Intensive care medicine
- Biology
- Good health and well-being
Funding
- ECEuropean CommissionAwards: FP7-242209-BIOSTAT-CHF, FP7-242209, 242209
- NINational Institutes of HealthAwards: HL131458, HL123647, NHLBI R01, R01 AG049762, AT008375
- NINational Institute on AgingAwards: R01 AG049762, AG049762
- NHNational Heart, Lung, and Blood InstituteAwards: R01 HL123647, R01HL107715, R01 HL131458, HL131458, R01HL126928